Johnson & Johnson posts Q1 net income of $5.24B, raises dividend by 3.1%
Johnson & Johnson posted Q1 net income of $5.24B ($2.14 per share) and adjusted EPS of $2.70, surpassing the $2.67 consensus, on $24.06B revenue versus $23.45B expected. It raised its quarterly dividend by 3.1% for a 64th consecutive year and maintained full-year guidance of $11.45–$11.65 EPS on $100.3–$101.3B revenue.
1. Q1 Earnings Beat
Johnson & Johnson posted Q1 net income of $5.24B, or $2.14 per share, and adjusted EPS of $2.70, both exceeding the $2.67 consensus. Revenue of $24.06B surpassed the $23.45B forecast.
2. Dividend Increase
The board approved a 3.1% increase in the quarterly dividend, marking the 64th consecutive annual raise.
3. Product Performance
Strong demand for Darzalex and Tremfya drove sales growth, offsetting a steep decline in Stelara revenue.
4. Outlook
J&J reaffirmed full-year EPS guidance of $11.45–$11.65 and revenue forecast of $100.3–$101.3B.